Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.
Case Number:
1:18-cv-01802
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 17, 2022
Roche Unit Nets $775M Deal In AstraZeneca IP Row
A month after AstraZeneca's Alexion Pharmaceuticals settled claims that its antibody product Ultomiris infringed patents held by Roche-owned rival Chugai Pharmaceutical Co. Ltd., Chugai's attorneys said Thursday the settlement netted their client $775 million.
-
February 15, 2022
Alexion, Chugai Settle Blood Drug IP Row On Day Of Trial
AstraZeneca's Alexion Pharmaceuticals settled claims it infringed patents held by Roche-owned rival Chugai Pharmaceutical Co. on the first day of an oft-delayed trial, a Delaware court filing shows.
-
February 10, 2022
IP Forecast: 9th Circ. To Hear Copyright Row With Shyamalan
The Ninth Circuit next week will hear a screenwriter's appeal of the dismissal of her case accusing M. Night Shyamalan of ripping off her indie film while making a TV thriller for Apple's streaming service as well as a subsequent order to pay attorney fees. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
January 05, 2022
Omicron Surge Reshuffles Patent Trial Plans Once Again
The beginning of January was shaping up to be a busy time for patent jury trials with judges scheduling several to kick off the new year, following a lull during the pandemic, but skyrocketing viral infections have led many of the trials to be postponed.
-
September 16, 2021
IP Forecast: Trial Lawyer School TM Fight Lands At 10th Circ.
Famed litigator Gerry Spence will ask a federal appeals court next week to reverse a trademark injunction in a bitter fight with his former legal training school. Here's a look at that case plus all the other major intellectual property matters on deck in the coming week.